ALB and Schnyder corneal dystrophy: The contribution of EAF P5K6 Alb as therapeutic to modify the severity of SCD is through supra plasma expander activity, which facilitates improved tissue oxygenation, and can be considered an anti-anemia therapeutic benefit [52].